NCT06853509View on ClinicalTrials.gov

Predicting Gastric Neoplasia in Patients with High-risk Endoscopic Features

Not yet recruitingOBSERVATIONAL
Enrollment

2,700

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2033

Conditions
Gastric Neoplasia
Interventions
OTHER

No Intervention: Observational Cohort

No Intervention: Observational Cohort

Trial Locations (1)

200040

Huadong hospital affiliated to Fudan university, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT06853509 - Predicting Gastric Neoplasia in Patients with High-risk Endoscopic Features | Biotech Hunter | Biotech Hunter